ADC Therapeutics
ADCT
ADCT
83 hedge funds and large institutions have $112M invested in ADC Therapeutics in 2024 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 33 increasing their positions, 16 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
83
Holders Change
+6
Holders Change %
+7.79%
% of All Funds
1.11%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
16
Increased
33
Reduced
16
Closed
10
Calls
$51K
Puts
$102K
Net Calls
-$51K
Net Calls Change
-$206K
Top Buyers
| 1 |
WP
1
Woodline Partners
San Francisco,
California
|
$3.85M |
| 2 |
O
2
OrbiMed
New York
|
$11.9M |
| 3 |
3
Morgan Stanley
New York
|
$7.87M |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$1.76M |
| 5 |
5
BNP Paribas Financial Markets
Paris,
France
|
$1.43M |
